Trial Profile
Pharmacokinetic study of olmesartan medoxomil/amlodipine 20/5 mg tablet in Chinese healthy adult volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jan 2022
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil/amlodipine (Primary)
- Indications Hypertension
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Daiichi Sankyo Pharmaceutical (Shanghai)
- 02 Jun 2016 New trial record